Lu Kangping, Wang Jingxuan, Song Ying, Zhao Shu, Liu Hang, Tang Dabei, Pan Bo, Zhao Hong, Zhang Qingyuan
Department of Medical Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Oncol Rep. 2015 Aug;34(2):995-1002. doi: 10.3892/or.2015.4025. Epub 2015 Jun 4.
MicroRNAs (miRNAs) are often aberrantly expressed in breast cancer and are postulated to play a role in its initiation and progression. In the present study, we found that the expression level of miR-24-3p was upregulated in breast cancer in comparison with the level in adjacent normal tissues. Overexpression of miR-24-3p was able to promote cell proliferation and inhibit cell apoptosis in MDA-MB-435 and MDA-MB-468 cells. With the bioinformatic method, we further identified that p27Kip1 is a direct target of miR-24-3p, and its protein level was negatively regulated by miR-24-3p. Therefore, the data reported here demonstrate that miR-24-3p is an important regulator in breast cancer, and imply that the miR-24-3p/p27Kip1 axis has potential as a therapeutic target for breast cancer.
微小RNA(miRNA)在乳腺癌中常常异常表达,并被推测在乳腺癌的发生和发展中发挥作用。在本研究中,我们发现与相邻正常组织相比,miR-24-3p在乳腺癌中的表达水平上调。miR-24-3p的过表达能够促进MDA-MB-435和MDA-MB-468细胞的增殖并抑制其凋亡。通过生物信息学方法,我们进一步确定p27Kip1是miR-24-3p的直接靶标,并且其蛋白水平受到miR-24-3p的负调控。因此,本文报道的数据表明miR-24-3p是乳腺癌中的一个重要调节因子,并提示miR-24-3p/p27Kip1轴具有作为乳腺癌治疗靶点的潜力。